Kuopio Angiogenesis Trial - KAT II

Description:

The goal of the Kuopio Angiogenesis Trial (KAT II) was to compare the efficacy of local vascular endothelial growth factor (VEGF) gene transfer versus placebo given during percutaneous transluminal coronary angioplasty (PTCA) and stenting.